Bluebird bio Current Cash

Bluebird bio (BLUE) currently reports a current cash of $79M as of March 2025. That compares with $210M in the prior-year period — down 62.9% year over year. Use the charts on this page to explore Bluebird bio's current cash history and peer comparisons.

Bluebird bio's current cash decreased from $210M to $79M — a 62.9% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bluebird bio reported $79M in current cash as of March 2025. That compares with $210M in the prior-year period — down 62.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $79M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bluebird bio, and consider following BLUE for alerts when major investors trade the stock.

Bluebird bio is classified in the Healthcare sector. On current cash, it currently shows $79M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLUE with unrelated industries.